Hongyan Wu

This study is testing whether a drug called diacerein can help treat metabolic fatty liver disease (MAFLD), a common condition where fat builds up in the liver. Researchers will give either diacerein or a placebo (inactive pill) to 74 adults with MAFLD to see if the drug reduces …